Andrew May

Andrew May serves as a Contracting Officer responsible for managing complex procurement actions across professional, scientific, and technical services, with a focus on ensuring compliance with federal acquisition regulations and promoting efficient, mission-driven outcomes. He oversees the full lifecycle of contract actions—from market research and solicitation development to award and administration—primarily supporting acquisitions in pharmaceutical manufacturing, healthcare technology, and management consulting domains. His role is critical in aligning procurement strategy with operational needs, ensuring transparency, competition, and regulatory integrity throughout the acquisition process. While specific contractor names are not available, Andrew May engages with a diverse range of vendors, including large primes, mid-tier firms, and small businesses, consistently fostering competitive environments that encourage innovation and performance-based outcomes. His contracting patterns reflect a preference for open competition, with the majority of actions conducted under full and open procedures, while still maintaining structured pathways for small business participation. Andrew demonstrates a measurable commitment to socioeconomic contracting, with 10.5% of his awards designated as Total Small Business Set-Asides under FAR 19.5. Though he rarely utilizes specialized set-asides such as 8(a), HUBZone, or SDVOSB, his consistent use of small business set-asides reflects a deliberate strategy to expand opportunities for qualified small entities without compromising acquisition efficiency or mission readiness. His primary procurement focus centers on NAICS 541990 (Other Professional Services), 325412 (Pharmaceutical Preparation Manufacturing), and 541611 (Management Consulting), indicating deep expertise in procuring clinical support services, laboratory and pharmaceutical production capabilities, and organizational efficiency solutions. He regularly handles requirements involving technical consulting, regulatory compliance support, and electromedical equipment sourcing, demonstrating a strong command of both service-based and manufacturing-related acquisition frameworks.